Symposium programme: (immuno) therapy against “Therapeutic vaccination and host-directed TB” Tuesday afternoon 30th January 2018 Programme 14.00 - 14.05 Opening and Welcome - Nick Drager, TBVI, the Netherlands, Chair: Frank Verreck (BPRC, the Netherlands) 14.05 14.30 Introductory and overarching overview - Stefan Kaufmann, MPIIB, Germany – Germany 14.30 15.00 Exploring host-pathogen interactions for host directed therapies - Dr. Ulrich Schaible, – Research Centre Borstel, Borstel, Germany 15.00 15.30 Evaluation of host-directed therapies against TB in the macaque model - Dr. Deepak – Kaushal, Tulane NHP Research Centre (TNPRC), Covington, United States 15.30 16.00 A perspective on therapeutic vaccination from the TB drug development space - – Prof. Eric Nuermberger, Johns Hopkins University, Baltimore, United States 16.00 16.30 Coffee break / snack – 16.30 17.00 Strategies for clinical development of therapeutic vaccines for DR-TB Prof. Dr. Mark - – Hatherill, South African Tuberculosis Initiative, University of Cape Town, South Africa 17.00 17.30 Therapeutic vaccines in HIV infection: challenges and future - Prof. Dr. Giuseppe – Pantaleo, Swiss Vaccine Research Institute, CHUV, Lausanne, Switzerland
Symposium programme: “Therapeutic vaccination and host-directed (immuno) therapy against TB” Tuesday afternoon 30th January 2018 Programme 14.00 - 14.05 Opening and Welcome - Nick Drager, TBVI, the Netherlands, Chair: Frank Verreck (BPRC, the Netherlands) 14.05 – 14.30 Introductory and overarching overview - Stefan Kaufmann, MPIIB, Germany Germany 14.30 – 15.00 Exploring host-pathogen interactions for host directed therapies - Dr. Ulrich Schaible, Research Centre Borstel, Borstel, Germany 15.00 – 15.30 Evaluation of host-directed therapies against TB in the macaque model - Dr. Deepak Kaushal, Tulane NHP Research Centre (TNPRC), Covington, United States 15.30 – 16.00 A perspective on therapeutic vaccination from the TB drug development space - Prof. Eric Nuermberger, Johns Hopkins University, Baltimore, United States 16.00 – 16.30 Coffee break / snack 16.30 – 17.00 Strategies for clinical development of therapeutic vaccines for DR-TB - Prof. Dr. Mark Hatherill, South African Tuberculosis Initiative, University of Cape Town, South Africa 17.00 – 17.30 Therapeutic vaccines in HIV infection: challenges and future - Prof. Dr. Giuseppe Pantaleo, Swiss Vaccine Research Institute, CHUV, Lausanne, Switzerland
Symposium-programme_final.docx